The ethical drug company Novo Nordisk will report earnings on Wednesday, January 31. Analysts expect the company to report EPS of $0.67 on revenue of $8.7 billion. This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Tags:$NVO Share: Mark W. Guthner, CFA Previous Post Economy & the Cost of Government BorrowingNext PostThe Week Ahead | 1/29/2024 You Might Also Like Update: United Continental Holdings, Inc. (UAL) August 1, 2018 Goldman Sachs: GS November 8, 2023 Fed Powell’s Statement and Adjustment to FITB Position June 20, 2019
You Might Also Like Update: United Continental Holdings, Inc. (UAL) August 1, 2018 Goldman Sachs: GS November 8, 2023 Fed Powell’s Statement and Adjustment to FITB Position June 20, 2019
